A phase I study of Rad-001 [everolimus] and sunitinib in metastatic renal cell carcinoma patients.
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2010
At a glance
- Drugs Everolimus; Sunitinib
- Indications Renal cancer
- Focus Adverse reactions
- 02 Mar 2010 Actual end date (Feb 2010) and actual number of patients (20) added as reported by ClinicalTrials.gov.
- 02 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 25 Feb 2009 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.